Envista Holdings (NVST) Valuation Check After Recent Share Price Gains And Longer Term Return Slowdown

Envista Holdings -0.35%

Envista Holdings

NVST

25.81

-0.35%

Envista Holdings stock: what recent performance signals for investors

Envista Holdings (NVST) shares recently closed at $23.84, with the move catching investor attention after a mix of short term pullbacks and gains over the past month and past 3 months.

That recent 1 day share price decline of 2.34% comes after a 30 day share price return of 8.36% and a 90 day share price return of 17.09%, while the 3 year total shareholder return of 37.82% and 5 year total shareholder return of 32.92% point to momentum that has faded over a longer horizon.

If Envista’s moves have you reassessing the dental space, it can be useful to see what else is out there across broader healthcare. Take a look at healthcare stocks.

With Envista trading near its recent analyst price target but sitting on an estimated 30% intrinsic discount, the key question is whether the current valuation still leaves upside on the table or already reflects future growth.

Most Popular Narrative: 11.7% Undervalued

Envista’s most followed narrative pegs fair value at $27.00 per share, above the recent $23.84 close, framing today’s price against a richer earnings outlook.

The net profit margin has risen significantly from roughly 7.29% to about 11.74%, implying a much stronger profitability profile in future periods.

The future P/E multiple has fallen markedly from about 22.3x to about 14.0x, suggesting a more conservative valuation framework for projected earnings.

Want to see what is sitting behind that margin step up and lower future multiple? The narrative leans on steady top line growth, reshaped profitability and disciplined valuation math that does not assume blue sky outcomes.

Result: Fair Value of $27.00 (UNDERVALUED)

However, that upbeat story still runs into real hurdles, including pressure on traditional dental products as providers adopt more digital tools and tighter pricing from large dental groups.

Build Your Own Envista Holdings Narrative

If you are not fully on board with this story or would rather lean on your own work, you can quickly pull the same data, pressure test every assumption, and build a version that fits your view, all in just a few minutes, then Do it your way.

A great starting point for your Envista Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If Envista has you thinking more broadly about where to put your next dollar, do not stop here. The right watchlist can make a real difference over time.

  • Target reliable cash payouts by scanning these 13 dividend stocks with yields > 3% that line up income potential with underlying fundamentals.
  • Spot early trends in automation and data science through these 24 AI penny stocks before they sit on everyone else’s radar.
  • Hunt for potential mispricings with these 864 undervalued stocks based on cash flows, so you are not just reacting to the headlines everyone else is reading.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.